13. Restructuring Charges

The restructuring charges recorded by the Company during the three and nine months ended June 30, 2018 were nominal. During the three and nine months ended June 30, 2017, the Company recorded restructuring charges of $0.8 million and $2.7 million, respectively. The charges during the three months ended June 30, 2017 was primarily related to severance in the Brooks Semiconductor Solutions Group segment. The charges during the nine months ended June 30, 2017 included $2.2 million in the Brooks Semiconductor Solutions Group segment, $0.2 million in the Brooks Life Sciences segment and $0.3 million related to a company-wide restructuring action.

The following is a summary of activity related to the Company’s restructuring charges for the three and nine months ended June 30, 2018 and 2017 (in thousands):


	Activity -Three Months Ended June 30, 2018
	Balance						Balance
	March 31,						June 30,
	2018		Expenses		Payments		2018
Total restructuring liabilities related to workforce termination benefits	$	416	$	82	$	(284)	$	214


	Activity -Three Months Ended June 30, 2017
	Balance						Balance
	March 31,						June 30,
	2017		Expenses		Payments		2017
Total restructuring liabilities related to workforce termination benefits	$	2,044	$	828	$	(1,182)	$	1,690


	Activity -Nine Months Ended June 30, 2018
	Balance						Balance
	September 30,						June 30,
	2017		Expenses		Payments		2018
Total restructuring liabilities related to workforce termination benefits	$	1,708	$	131	$	(1,625)	$	214


	Activity -Nine Months Ended June 30, 2017
	Balance						Balance
	September 30,						June 30,
	2016		Expenses		Payments		2017
Total restructuring liabilities	$	5,939	$	2,663	$	(6,912)	$	1,690

As of June 30, 2018, accrued restructuring costs of $0.2 million were primarily attributable to the restructuring actions within the Brooks Life Sciences segment. Accrued restructuring costs are expected to be paid within the next twelve months. Please refer to Note 15, “Restructuring and Other Charges” to the Company’s consolidated financial statements included in the 2017 Annual Report on Form 10-K for further information on the restructuring actions discussed above.